These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15540608)

  • 1. A biochemical approach for detecting interactions between peptides from the HIV gp120 glycoprotein and a CD4 sequence.
    Chersi A; Falasca G; Malorni W
    Z Naturforsch C J Biosci; 2004; 59(9-10):734-8. PubMed ID: 15540608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short synthetic peptides derived from viral proteins compete with HIV gp120 for the binding to CD4 receptors.
    Chersi A; Pugliese O; Federico A; Viora M
    Viral Immunol; 2000; 13(4):547-54. PubMed ID: 11192301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The C4 region as a target for HIV entry inhibitors--NMR mapping of the interacting segments of T20 and gp120.
    Moseri A; Biron Z; Arshava B; Scherf T; Naider F; Anglister J
    FEBS J; 2015 Dec; 282(24):4643-57. PubMed ID: 26432362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Range of CD4-Bound Conformations of HIV-1 gp120, as Defined Using Conditional CD4-Induced Antibodies.
    Kaplan G; Roitburd-Berman A; Lewis GK; Gershoni JM
    J Virol; 2016 May; 90(9):4481-4493. PubMed ID: 26889042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection.
    Shapira-Nahor O; Golding H; Vujcic LK; Resto-Ruiz S; Fields RL; Robey FA
    Cell Immunol; 1990 Jun; 128(1):101-17. PubMed ID: 1971526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A functional, discontinuous HIV-1 gp120 C3/C4 domain-derived, branched, synthetic peptide that binds to CD4 and inhibits MIP-1alpha chemokine binding.
    Howie SE; Fernandes ML; Heslop I; Hewson TJ; Cotton GJ; Moore MJ; Innes D; Ramage R; Harrison DJ
    FASEB J; 1999 Mar; 13(3):503-11. PubMed ID: 10064617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage randomization in a charybdotoxin scaffold leads to CD4-mimetic recognition motifs that bind HIV-1 envelope through non-aromatic sequences.
    Li C; Dowd CS; Zhang W; Chaiken IM
    J Pept Res; 2001 Jun; 57(6):507-18. PubMed ID: 11437954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural studies on synthetic peptides from the principal neutralizing domain of HIV-1 gp120 that bind to CD4 and enhance HIV-1 infection.
    Dettin M; De Rossi A; Autiero M; Guardiola J; Chieco-Bianchi L; Di Bello C
    Biochem Biophys Res Commun; 1993 Mar; 191(2):364-70. PubMed ID: 8460995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competition of HLA-DR and a beta 2 domain peptide for HIV envelope glycoprotein gp120 binding to CD4.
    Autiero M; Houlgatte R; Martin M; Auffray C; Guardiola J; Piatier-Tonneau D
    Int Immunol; 1995 Feb; 7(2):191-7. PubMed ID: 7734415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and characterization of a single-chain polypeptide analogue of the human immunodeficiency virus type 1 gp120-CD4 receptor complex.
    Fouts TR; Tuskan R; Godfrey K; Reitz M; Hone D; Lewis GK; DeVico AL
    J Virol; 2000 Dec; 74(24):11427-36. PubMed ID: 11090138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection.
    Zanotto C; Calderazzo F; Dettin M; Di Bello C; Autiero M; Guardiola J; Chieco-Bianchi L; De Rossi A
    Virology; 1995 Feb; 206(2):807-16. PubMed ID: 7856094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
    Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J
    Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement and induction of HIV-1 infection through an assembled peptide derived from the CD4 binding site of gp120.
    Groß A; Rödel K; Kneidl B; Donhauser N; Mössl M; Lump E; Münch J; Schmidt B; Eichler J
    Chembiochem; 2015 Feb; 16(3):446-54. PubMed ID: 25639621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CD4 and major histocompatibility complex functional peptide sites and their homology with oligopeptides from human immunodeficiency virus type 1 glycoprotein gp120: role in AIDS pathogenesis.
    Zagury JF; Bernard J; Achour A; Astgen A; Lachgar A; Fall L; Carelli C; Issing W; Mbika JP; Picard O
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7573-7. PubMed ID: 8356059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine-sulfate isosteres of CCR5 N-terminus as tools for studying HIV-1 entry.
    Lam SN; Acharya P; Wyatt R; Kwong PD; Bewley CA
    Bioorg Med Chem; 2008 Dec; 16(23):10113-20. PubMed ID: 18952441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short peptides with induced beta-turn inhibit the interaction between HIV-1 gp120 and CD4.
    Choi YH; Rho WS; Kim ND; Park SJ; Shin DH; Kim JW; Im SH; Won HS; Lee CW; Chae CB; Sung YC
    J Med Chem; 2001 Apr; 44(9):1356-63. PubMed ID: 11311058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a synthetic peptide that mimics an HIV glycoprotein 120 envelope conformational determinant exposed following ligation of glycoprotein 120 by CD4.
    Weinberg J; Liao HX; Torres JV; Matthews TJ; Robinson J; Haynes BF
    AIDS Res Hum Retroviruses; 1997 May; 13(8):657-64. PubMed ID: 9168234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific interaction of conformational polypeptides derived from HIV gp120 with human T lymphocyte CD4 receptor.
    Liu M; Zeng J; Robey FA
    Immunol Lett; 1998 Aug; 63(1):27-32. PubMed ID: 9719435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of anti-HIV activity of succinylated human serum albumin.
    Kuipers ME; vd Berg M; Swart PJ; Laman JD; Meijer DK; Koppelman MH; Huisman H
    Biochem Pharmacol; 1999 Apr; 57(8):889-98. PubMed ID: 10086322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.